All Industries

First Phosphate signs MOU with Ultion Technologies for LFP and LFP Cathode

First Phosphate Corp.

First Phosphate Corp CEO John Passalacqua joined Steve Darling from Proactive to share shared significant news. The company has signed a memorandum of understanding (MOU) with Ultion Technologies, based in Las Vegas, Nevada, for the procurement of lithium iron phosphate (LFP) and lithium iron manganese phosphate (LFMP) cathode active material. Passalacqua provided insights into the scope of this MOU, revealing that the LFP technology covered by the agreement is already in production across two facilities. One facility boasts an impressive annual capacity of 10,000 tonnes, while the other can produce up to 50,000 tonnes annually. This extensive production capacity underscores the scale of the operation. To put the potential market value of 50,000 tonnes of LFP cathode active material into perspective, Passalacqua highlighted that it could range from US$625 million to US$1.25 billion, based on recent market price ranges. In addition to LFP, the MOU also encompasses LFMP technology, which is currently in development and being produced at a quantity of several tonnes per month. These developments showcase the strategic importance of First Phosphate Corp's partnership with Ultion Technologies, positioning the company to capitalize on the burgeoning demand for lithium-based materials in the rapidly expanding battery and clean energy sectors. This agreement reflects the company's commitment to providing essential materials for sustainable and renewable energy solutions while contributing to the growth of the global lithium supply chain. Contact Details Proactive Investors Canada +1 604-688-8158 na-editorial@proactiveinvestors.com

December 11, 2023 01:26 PM Eastern Standard Time

Video

News Release

Willow Bioscience plans to advance development program with Nasdaq-listed company

Willow Biosciences Inc.

Willow Bioscience CEO Dr Chris Savile joined Steve Darling from Proactive to share a significant development. The company has unveiled a noteworthy partnership with a Nasdaq-listed biopharmaceutical company, with a shared objective of forging precise and efficient manufacturing pathways for advanced intermediates and high-value active pharmaceutical ingredients (APIs). Savile provided insights into this partnership's progress, revealing that the initial phase of the feasibility program, which leveraged Willow's BioOxiTM platform, surpassed expectations. In light of this success, the partner has committed to advancing the program further toward commercialization. This next phase will encompass additional research and development efforts, as well as scaling up production. One of the notable aspects of this collaboration is the revenue-generating potential for Willow Bioscience. The company anticipates revenue streams from research fees, aligning perfectly with its strategic focus on near-term revenue generation from programs with relatively short timelines for commercial revenue realization. Additionally, Willow expects to commence revenue generation from the commercial supply of a crucial advanced intermediate through its manufacturing network as early as 2024. This partnership represents a significant milestone for Willow Bioscience, underscoring its commitment to advancing cutting-edge biopharmaceutical solutions and capitalizing on opportunities in the pharmaceutical industry. Savile also shared the company has reported its third-quarter financials numbers that showed the company has seen record revenues for the third quarter and the signing of two new program agreements, and advanced three programs to the next phase of development toward commercialization. Contact Details Proactive Investors +1 604-688-8158 na-editorial@proactiveinvestors.com

December 11, 2023 01:16 PM Eastern Standard Time

Video

News Release

Galaxy Fox's Stage 3 is Almost Sold-Out. Here's Why It’s So Hot

RoundHouse Media

Watching for boisterous early movers proved a reliable strategy for turning modest sums into huge crypto stacks in 2017 and 2021. Luckily for investors, 2024 will offer a repeat of the pattern, and finding these small-cap gems before they launch is a one-way ticket to netting 1000X returns in this cycle. Galaxy Fox ’s ( $GFOX ) stage 3 is about to sell out. Could it be one of these early movers and a top crypto to buy in 2023? Here’s what we know. Galaxy Fox ($GFOX): A New Generation of P2E Galaxy Fox is leading the next generation of play-to-earn tokens, and this unique hybrid has risen rapidly, establishing itself as a top crypto to invest in before the 2024 GameFi-driven bull market. One of the only tokens uniquely positioned to enjoy two narratives. Galaxy Fox’s viral aesthetic, micro-cap, and deflationary tokenomics put it in the memecoin race, and its runner game puts it on the GameFi stage. The team has purposely enhanced the protocol's viral nature, allowing the possibility of it mooning overnight. A highly novel introduction from Galaxy Fox is a protocol-level marketing budget. Marketing is the key component of success in a bull. Galaxy Fox routing 2% of buy and sell taxes to the protocol Treasury- responsible for funding community initiatives and marketing efforts- outlines a constant revenue stream for ecosystem expansion. Additionally, revenue generated by real-world merchandise feeds the Treasury. As marketing attracts more users, the Treasury will accrue greater revenue, and further efforts will draw in new users. This is how Galaxy Fox activates a powerful flywheel for acquiring users. This business sense naturally makes $GFOX one of the best cryptocurrencies to buy for people who understand marketing dynamics and the importance of new users. All users in the Galaxy Fox ecosystem can compete in its Web3 runner game. Those skilled enough to end the season in the top 20% will earn prizes exchangeable for $GFOX tokens- a top crypto to buy in 2023 for any users confident in their gaming abilities. But Galaxy Fox offers more earning opportunities and moves away from the classic play-to-earn model, which only rewards a small percentage of skilled players. Instead, everybody staking $GFOX earns. Investors earn residual income via Stargate – the protocol’s staking module. Stargate accrues 2% of all ecosystem transactions and distributes these among stakers. Using taxes as opposed to emissions means these rewards have no theoretical cap and will grow in tandem as the ecosystem expands. $GFOX Full Scale Rush Into Stage 3 Galaxy Fox has blitzed past $750,000 and already entered stage 3. Those lucky enough to buy during stage 1 have already enjoyed two price increases. Given its current pace, investors who want to lock in the remaining seven price increases will have to move fast. The window of opportunity steadily closes- the days when investors can buy discounted $GFOX are numbered. Closing Thoughts: Move Fast and Securing Upside Crypto has always rewarded investors who move fast, take risks, and try new things. Galaxy Fox’s genre-bending approach to product development- releasing a memecoin/ P2E hybrid- makes it one of this year’s most exciting propositions. And its sub $1 million market cap looks primed to fly in the current market environment. Participate in the presale today and enjoy all the incoming staggered price increases. There is no telling how high $GFOX can soar, and entering price discovery in current market conditions could see prolonged vertical growth. Discover why analysts call $GFOX a top crypto to buy in 2023 and get an allocation before the GameFi bull market begins. Learn more about $GFOX here: Visit Galaxy Fox Presale | Join the Community Memecoin market is saturated with silly dog coin knock-offs and dodgy Pepe joke coins. What was once a thriving and fun-filled space has lately devolved into a wasteland of coins that lack real utility or serious development â or even something just to make you laugh, like OG memcoins of the past Doge and Shiba Inu once inspired. Contact Details Team media@galaxyfox.io

December 11, 2023 01:00 PM Eastern Standard Time

Bitget Makes A Multimillion-Dollar Investment in Layer 2 Consumer-centric Blockchain Morph

Bitget

Morph, a Layer 2 consumer blockchain for value-driven dApps, announced the closing of a multimillion-dollar investment from the Web3 and cryptocurrency trading platform Bitget. “Morph has a stellar team endowed with experience, a vibrant multicultural approach, and industry-leading strategic capabilities for fostering mass adoption. It has demonstrated tangible progress in its commitment to a unique vision of a consumer blockchain. With Bitget’s dedication to forging ties with exemplary Web3 entities, we’ve embraced Morph in a spirit of collaboration,” said Bitget Managing Director Gracy Chen. Morph’s roll-up tech intelligently combines the best features of Optimistic and ZK roll-ups to reduce cost barriers, accelerate dispute resolution, and ensure flexible and secure transactions for dApps of all sizes. At the heart of the ecosystem is a decentralized sequencer network eliminating central points of control, countering MEV dominance, and guaranteeing consumers scalable, inexpensive, and rapid Layer 2 transactions. “We are extremely grateful for Bitget’s support,” said Morph Co-Founder and CEO Cecilia Hsueh. “The recent capital infusion showcases our incubator’s confidence in Morph’s UVP and sets the stage for the seed funding round. Our proactive financial strategy is crafted to tackle an aggressive roadmap and product development timeline to reform the Layer 2 landscape.” Bitget’s investment symbolizes a convergence of shared visions for value-driven dApps, while the two organizations are uniquely positioned to build a thriving ecosystem and accelerate user adoption. Benefiting from the extensive user base of over 20 million on Bitget and 12 million on Bitget Wallet, Morph will be able to leverage its new partner’s wealth of knowledge and strategies. According to Hsueh, Morph will also implement the exchange’s native affiliate system, extending to a massive follower base of over 50 million, engineered to drive initial user acquisition and long-lasting participation and investment. Morph has also forged a strategic partnership with Foresight Ventures, a Singapore-based crypto fund that recently announced its acquisition of a majority stake in the leading media group, The Block. This strategic move encompasses a broader expansion. Morph expects comprehensive growth in the upcoming months, covering its technical side, larger ecosystem, marketing, community management, and additional operational divisions. Moreover, the company’s Testnet Beta is scheduled to launch in early January, 2024, with mainnet beta expected to go live in Q2 2024. About Bitget Established in 2018, Bitget is the world’s leading cryptocurrency exchange and web3 company. Serving over 20 million users in 100+ countries and regions, the Bitget exchange is committed to helping users trade smarter with its pioneering copy trading feature and other trading solutions. Formerly known as BitKeep, Bitget Wallet is a world-class multi-chain crypto wallet that offers an array of comprehensive Web3 solutions and features including wallet functionality, swap, NFT Marketplace, DApp browser, and more. Bitget inspires individuals to embrace crypto through collaborations with credible partners, including legendary Argentinian footballer Lionel Messi and official eSports events organizer PGL. Website | Twitter | Telegram | LinkedIn | Discord About Morph Morph is a transparent, community-driven Layer-2 solution. Combining the best of OP and ZK rollups, it offers unmatched scalability and security, aiming to lay a foundation for an ecosystem of consumer-focused, value-driven DApps. Through its hallmark features, such as a Decentralized Sequencer Network, Responsive Validity Proof (RVP) system, and modular design, the project delivers efficient and flexible scaling while preserving the initial security, availability, and compatibility of the Ethereum network. Website | Twitter | Medium | Discord About Foresight Ventures Foresight Ventures is a crypto fund focused on backing Web3 projects that embody an ethos of decentralization while moving crypto toward long-term, mainstream adoption. With an impressive global industry network at our disposal, we pride ourselves on unparalleled media connections that enable us to elevate our projects to remarkable visibility and influence. Foresight Ventures manages multiple funds: a VC fund, an actively managed secondary fund, a multi-strategy FOF, and a private market secondary fund. As a one-stop shop for crypto projects, Foresight Ventures provides incubation, investment, and advisory throughout the project life cycle. Website | LinkedIn | Twitter Contact Details Bitget Rachel Cheung media@bitget.com Company Website https://www.bitget.com/

December 11, 2023 11:55 AM Eastern Standard Time

Image

Empire Resources MD bullish on prospects

Empire Resources Ltd

Empire Resources Ltd (ASX:ERL) Managing Director Sean Richardson speaks to Thomas Warner from Proactive about recent progress at the gold and copper focused exploration and development company. Richardson highlights the successful divestment of an investment in NTM Gold during the COVID period, generating significant profits. The company has also undertaken exploration programs across its three project areas, experiencing both successes and challenges. He expresses optimism about gold prices but acknowledged rising costs. Regarding copper, he sees potential for long-term growth, citing recent price improvements. In the last 12 months, Empire Resources has strategically assessed market opportunities, aiming for organic growth in exploration and business development. Richardson encourages investors to look beyond assets and consider the team's achievements. He emphasises the team's dedication to developing and expanding the business. "We're a bit luck a duck on a pond, paddling very hard underneath and working hard to develop and grow the business - both in an organic fashion with our exploration activities but on the business development front as well... We're really bullish on our team and what we can deliver." Contact Details Proactive UK Ltd Proactive UK Ltd +44 20 7989 0813 uk@proactiveinvestors.com

December 11, 2023 10:16 AM Eastern Standard Time

Video

Bloomsbury Publishing successfully surfing the BookTok and fantasy waves

Bloomsbury Publishing PLC

Bloomsbury Publishing PLC (LSE:BMY) Group Finance Director Penny Scott-Bayfield speaks to Thomas Warner from Proactive after the independent publishing house released a trading update for 2023. Scott-Bayfield says that Bloomsbury expects its revenue and profit to significantly exceeded market expectations for the year to 29 February 2029, with revenues likely to surpass £274 million and profits £33 million. She explains some of the reasons for the company's strong performance, particularly in the fantasy sector, attributing some of the success to the books of Sarah J. Maas. Her 15 titles have become an important part of the Bloomsbury portfolio. Scott-Bayfield also highlights the impact of social media on the publishing industry, citing 'BookTok' on TikTok as a major positive influence, comparable to the Harry Potter phenomenon. This social media presence has attracted a younger audience and rejuvenated certain market segments. Additionally, she discusses the company's strategic shift away from a heavy reliance on Christmas sales. This diversification, including successful titles like those by Sarah J. Maas that are often bought for personal use rather than as gifts, reflects the strength and balance of Bloomsbury's portfolio. Contact Details Proactive UK Ltd +44 20 7989 0813 uk@proactiveinvestors.com

December 11, 2023 10:12 AM Eastern Standard Time

Video

USA Benefits Group Partners with AmeriLife to Expand Agent Opportunities & Serve More Clients

AmeriLife

AmeriLife Group, LLC (“AmeriLife”), a national leader in developing, marketing, and distributing life and health insurance, annuities, and retirement planning solutions, announced today that it has partnered with USA Benefits Group, a fast-growing, national health brokerage dedicated to delivering the highest quality products, service, and support to independent agencies, agents, and their clients. Per the agreement, terms of the deal were not disclosed. “We see this partnership as a power play to further USA Benefits Group's explosive growth,” said Rick Banville, CEO of USA Benefits Group. “AmeriLife is a rapidly expanding giant in the industry who takes the pressure off of agencies like ours through resources like HR, payroll, compliance, legal, marketing, recruiting, and technology so we can do what we do best: recruit and train agents and agencies to be successful. We are very excited about our bright future together.” “We are so grateful and honored to become partners with AmeriLife,” added Jessica Banville, president of USA Benefits Group. “We are thrilled that our agents and clients will benefit from an even larger portfolio of products and support. This partnership will give us even greater opportunity in making the industry better as we continue to develop training systems that bring success to all. We are stronger together!” For more than three decades, USA Benefits Group has been at the forefront of helping agents and their clients navigate the complexities of health and ancillary insurance (including ACA and ACA alternatives) for the under-65 market. Over the years, the company has expanded its portfolio to include Medicare Advantage and Medicare Supplement insurance, life insurance, and health insurance benefits for small businesses, as well as developed proprietary tools and training for its insurance professionals to succeed and thrive. Headquartered in nearby Spring Hill, Fla., USA Benefits Group boasts nearly 2,000 independent contracted agents nationwide. Now, with access to AmeriLife’s best-in-class resources, deep product portfolio, and industry expertise and leadership, USA Benefits Group is primed to supercharge its growth and deliver even more value to beneficiaries across the United States. “I’m excited to welcome Rick, Jessica and the USA Benefits Group family to ours,” said Scotty Elliott, Chief Distribution Officer for AmeriLife Health. “Our shared values and commitment to excellence in service makes this a winning partnership right out of the gate, and I can’t wait to see what we can accomplish together.” ### About USA Benefits Group USA Benefits Group is a nationwide insurance agency dedicated to the principles of service, integrity, professionalism and diversity. The company provides an extensive range of insurance products and pledges to honor its commitment to its producers, clients and carriers by holding itself to the highest ethical standards. Everything that USA Benefits Group does is designed to ensure that its customers are presented quality products with a “Servant’s Heart” and a goal of exceeding expectations. For more information, visit USABG.com. About AmeriLife AmeriLife’s strength is its mission: to provide insurance and retirement solutions to help people live longer, healthier lives. In doing so, AmeriLife has become recognized as a leader in developing, marketing, and distributing life and health insurance, annuities and retirement planning solutions to enhance the lives of pre-retirees and retirees across the United States. For more than 50 years, AmeriLife has partnered with top insurance carriers to provide value and quality to customers served through a distribution network of over 300,000 insurance agents and advisors and 120 marketing organizations and insurance agency locations nationwide. For more information, visit AmeriLife.com, and follow AmeriLife on Facebook and LinkedIn. Contact Details Media Jeff Maldonado +1 321-297-1112 jmaldonado@amerilife.com Partnership Inquiries Patrick Nichols +1 727-726-0726 pnichols@amerilife.com Company Website https://amerilife.com/

December 11, 2023 10:10 AM Eastern Standard Time

Faron Pharmaceuticals presents "very positive" Phase 1 data at ASH Conference

Faron Pharmaceuticals Oy

Faron Pharmaceuticals Limited (AIM:FARN, OTC:FPHAF) chief executive Dr Markku Jalkanen speaks to Thomas Warner from Proactive London after the clinical stage biopharmaceutical company announced "very positive" Phase 1 data from the ongoing BEXMAB study in myeloid malignancies. The data is being presented at the 65th American Society of Hematology (ASH) Annual Meeting & Exposition taking place until tomorrow, December 12, 2023, in San Diego, California, and virtually. Jalkanen says the data reveals a promising response in patients, especially in inducing myeloid differentiation in Myelodysplastic Syndrome (MDS), a condition with limited treatment options Typically, patients with this type of cancer have a life expectancy of around 24 months, making these results particularly significant. Investors and shareholders have responded positively to this latest news, as the trial shows a response rate potentially 5 to 10 times higher than the current standard of care. Faron Pharmaceuticals is now preparing to advance to the next trial phases and is exploring potential partnerships. Regarding the company's overall performance in 2023, Dr. Jalkanen expresses satisfaction with Faron's ability to maintain and even increase its pace, with promising data accumulating from ongoing trials and the initiation of new ones. The company is targeting a marketing approval application by 2025, staying on track with its previously set goals. Contact Details Proactive UK Ltd +44 20 7989 0813 uk@proactiveinvestors.com

December 11, 2023 10:09 AM Eastern Standard Time

Video

ATOME Energy CEO banging the drum for green ammonia at COP28

ATOME Energy PLC

ATOME Energy PLC (AIM:ATOM) CEO Olivier Mussat speaks to Thomas Warner from Dubai, where where ATOME is attending COP28. He says the company, which describes itself as the only international green fertiliser project development company on the London Stock Exchange, was invited as a key player among 50 hydrogen projects. He adds that the invitation is a testament to Atome's hard work in reducing emissions in agriculture, a sector more polluting than shipping and aviation combined. Mussat's says that despite a packed schedule, including recent EPC negotiations in London, his primary focus remains on the company's growth and impact. Atome Energy is intensifying its focus on the lucrative fertiliser sector, a market worth $200 billion annually. Mussat emphasises the vital role of hydrogen in decarbonising agriculture, aligning perfectly with investor interests and current market trends. Mussat also provides an update on Atome's Villeta Project. Looking forward to 2024, he anticipates exciting announcements and advancements, buoyed by substantial capital influx from major investors. Contact Details Proactive UK Ltd +44 20 7989 0813 uk@proactiveinvestors.com

December 11, 2023 10:04 AM Eastern Standard Time

Video

1 ... 573 574 575 576 577 ... 3765